Selling And Administration Expenses Zmiana Data
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Exelixis USD 138.14M 3.58M 2023-09
Immunic USD 3.77M 75K 2023-09
Incyte USD 293.86M 25.97M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09
Xoma USD 6.37M 591K 2023-09



Prothena Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.